Abstract
Introduction
Laryngeal cancer is the most common form of cancer in the head and neck area and constitutes 2% of all cancers in adults (1) . The incidence varies between different countries and has shown an increasing trend in many studies (2) . Ninety percent of tumor cases are squamous cell carcinomas (SCCs), and the main predisposing factors are smoking and alcohol. Viral infections, malnutrition, and local dietary habits are also factors in the etiology of laryngeal cancer (3) .
Human papillomavirus (HPV) is a small DNA virus of the family Papovaviridae, which generally infects squamous cells. More than 100 types of HPV have been defined (4) . Biomolecular studies reveal that specific mechanisms play roles in HPV-based carcinogenesis, and it is assumed that there is a relationship between HPV infection and cancers of the head and neck. Many studies of the frequency of HPV in head and neck cancers reported 34.5% as a positive result (5) . However, the localization of a certain tumor group varies widely, between 7% and 59%, according to method or patient characteristic (6) .
In HPV detection and typing, there is increasing interest in the use of nucleic acid amplification tests for formalin-fixed paraffin-embedded tissues. The detection of viral nucleic acids in formalin-fixed paraffin-embedded tissues can be complicated, as a result of excessive fixation and long-term secondary viral DNA/RNA degradation. However, such specimens are useful for HPV detection when fresh or frozen tissue can not be obtained and because most surgical pathology specimens are formalin-fixed paraffin-embedded tissues (7) . Today, HPV detection in formalin-fixed paraffin-embedded tissues is based on immunohistochemistry, primarily replacing protein markers and in situ hybridization (ISH) for HPV DNA. Immunohistochemical methods have high sensitivity but low specificity. On the other hand, ISH methods are specific but have low sensitivity, and thus, the findings can be difficult to assess. Compared to immunohistochemistry and ISH, the use of nucleic acid amplification tests provides increased analytic sensitivity and specificity and thus can supplement these techniques (8) .
The key factor in apoptosis integration with the cell cycle is p-53 protein, which is a tumor-suppressing gene product (9) . Many studies reported mutant p53 protein in larynx SCCs. However, it is controversial whether this is an indicator of poor prognosis or not. Some studies indicate that the index of tumor suppressor gene protein is related to a poor prognosis, whereas others suggest the opposite (10-12).
There is a good correlation between the amount of mitosis in tumor tissue and nuclear immunoreactivity of Ki-67, which indicates cell proliferation (12) . The prognostic importance of cell proliferation is controversial in larynx SCCs. The literature includes articles reporting that high Ki-67 proliferation index is a bad prognostic indicator (13) . On the other hand, some studies report no relationship to patient survival (11) .
This study investigated the presence of HPV in larynx SCCs via an immunohistochemical method and the HPV GenoArray test, which is a commercial polymerase chain reaction (PCR) array hybridization method. In addition, this study presents p53 and Ki-67 expression, revealing the relationship of these indicators with the presence of HPV and clinicopathological parameters.
Materials and Methods

Patients
This study retrospectively included 47 cases that were operated on for larynx SCC at the Otorhinolaryngology Clinic of Adnan Menderes University, Turkey. Paraffin block samples obtained from patients were chosen from the archive of the Pathology Department, and cross-sections of these blocks were tested for immunohistochemistry and PCR. Clinical data of the patients were recorded.
Immunohistochemical staining
Hematoxylin and eosin (H&E)-stained preparates of cases were re-examined. Cross-sections were chosen from blocks that were necrosis-free or those containing minimum necrosis. Immunohistochemical staining was via the avidin-biotin complex system. Pursuant to staining, cross-sections were examined under an optical microscope (Olympus BX51, Tokyo, Japan) at 4×, 10×, 20×, and 40× magnification. Nuclear staining was assessed for all immunohistochemical stains. In the most intensely stained area, at least 200 cells were found. For Ki-67 and p53, the staining percentages were scored as follows: less than 5%: 0; 5-10%: +; 11-20%: ++; and more than 20%: +++. For panHPV, HPV-16, and HPV-18, semi-quantitative scores were "0" for no staining, "+" for focal staining, and "++" for extensive staining.
HybriBio HPV genoarray test
For PCR and genotyping, between 10 and 20 leaf cross-sections, 5-10 microns in thickness, were obtained from paraffin blocks. Specimens were tested with a HybriBio HPV GenoArray diagnostic kit (GenoArray, HybriBio Ltd., Hong Kong). This test kit combines PCR and hybridization methods and can qualitatively detect 21 types of HPV. The test offers a macro-array format, through which HPV genotype-specific oligonucleotide probes are immobilized on a plastic membrane (14) . The sensitivity of the method is 4-89 genome copies/µl and varies by HPV genotype. It is also reported that there is no cross-reactivity between different HPV types during hybridization (15) . A commercial NucleoSpin Tissue mini column (Macherey-Nagel, Duren, Germany) isolation kit was used for the removal of paraffin from tissue and for DNA isolation. Following DNA isolation, HPV typing was conducted at three stages: increase of DNA via PCR, hybridization, and assessment of the results. For the increase of HPV DNA with PCR, 23.24 μl PCR mix, 0.75 μl DNA Taq polymerase, and 1 μl isolated DNA were added to PCR tubes for each specimen, in line with the manufacturer's instructions. PCR tubes that were prepared for the 47 specimens were placed in an Eppendorf-brand thermal cycler device for the amplification stage. The amplification process consisted of denaturation at 95°C for 9 min with a thermal cycler; then, a program comprising 40 cycles at 95°C for 20 sec, at 55°C for 30 sec, and at 72°C for 30 sec; and a final extension for 5 min at 72°C.
For the hybridization process, square-shaped hybridization membranes were placed in a HybriMax device. A mixture of 0.5 μl heated hybridization buffer and 20 μl PCR products was added to each specimen. Following processes conducted in accordance with the method, wet membranes were left to dry, and the place of purple dots on the membranes was assessed by eye. The accuracy of the test was assessed by the presence of amplification points in the first well of the membrane and the dot in the well below, indicating that the hybridization process was completed. A negative result was determined via the presence of amplification and hybridization dots combined with a lack of dots on the membranes in the wells. A positive result was indicated by the presence of amplification and hybridization dots, combined with the occurrence of dot/s according to the localization of 21 HPV types (the kit includes high-risk group: HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 and low-risk group: 6, 11, 42, 43, 44, 53, and CP8304).
Statistical analysis
In the test for Ki-67 and p53, staining between 0% and 10% was considered low grade, and >10% was considered high-grade staining. In the examination of PanHPV, HPV-16, and HPV-18, focal and extensive staining was considered positive; those without staining were considered negative.
Statistical analysis was conducted with Statistical Package for the Social Sciences (SPSS Inc., Chicago, IL, USA), version 14.0 for Windows. Definitive statistics used number and percentages; intergroup comparisons used chi-square and Fisher's exact test, and comparisons between dependent groups used the McNemar test. A p-value <0.05 was considered to be significant.
Results
Clinical and pathologic data of the cases are presented in Table 1 .
In the p53 staining via the immunohistochemical method, low-grade staining was detected in 22 (46.8%) cases, and high-grade staining was detected in 25 (53.2%) cases. No significant difference was found between p53 and smoking (p=0.611), tumor localization (p=0.927), neck metastasis (p=0.790), T phase (p=0.381), panHPV staining (p=0.053), HPV-16 staining (p=0.163), and Ki-67 staining (p=0.210).
Histological grade showed that as differentiation decreased, p53 expression increased (p=0.041).
In the immunohistochemical Ki-67 staining, low-grade staining was detected in 19 (40.4%) cases, and high-grade staining was detected in 28 (59.6%) cases. No significant difference was found between Ki-67 and smoking (p=0.137), tumor localization (p=0.990), neck metastasis (p=1.00), histological grade (p=0.439), and T phase (p=1.000). When comparing Ki-67 and panHPV (p=0.004) and HPV-16 (p=0.002) staining, the expression of Ki-67 was higher in positive cases (Figure 1 ).
In panHPV staining via the immunohistochemical method, negative staining was detected in 25 (53.2%) cases, and positive staining was detected in 22 (46.8%) cases. In the HPV-16 staining, negative staining was detected in 27 (57.4%) cases, and positive staining was detected in 20 (42.6%) cases. None of the patients showed positive Figure 2 ).
Polyclonal HPV positivity was detected in 15 (31.9%) cases via the PCR array hybridization method. HPV-16 was detected in 5 (10.6%) cases, HPV-31 was detected in 1 (2.1%), HPV-52 was detected in 1 (2.1%) case, HPV-53 was detected in 5 (10.6%) cases, HPV16 and HPV-5 were detected in 1 (2.1%) case, and HPV-16 and HPV-68 were detected in 2 (4.3%) cases (Figure 3 ). No significant difference was found between HPV PCR positivity and smoking (p=1.000), tumor localization (p=0.318), neck metastasis (p=0.725), histological grade (p=0.453), and T phase (p=0.414). Contrary to the literature, HPV-68 was found in two cases (Table 2 ).
There was no significant difference between the immunohistochemical panHPV results and HPV (PCR) methods (p=0.143). When comparing the HPV16 (PCR) results with immunohistochemical HPV-16 positivity, a significant difference (p=0.000) was found, and immunohistochemical positivity was observed in cases with HPV-16. HPV-18 was not detected with these two methods. In HPV (PCR)-positive cases, no significant relationship was detected with p53 (p=0.989); on the other hand, a statistically significant relationship was detected with Ki-67 (p=0.01) staining.
Discussion
Most laryngeal cancers are SCCs (16) . In the literature, it is reported that 60% of larynx cancers are glottic, 40% is supraglottic, and only 1% or fewer are subglottic (17) . In this study, glottic tumor localization (42.6%) was most common.
Smoking and alcohol consumption are the most important etiologic factors in laryngeal cancer (18, 19) . Smoking is the most common environmental factor, both as an initiator and progressor (20) . The prevalence of smoking is lower among women than men. It is assumed that passive smokers bear the same risk, although this has not yet been demonstrated (19) . Low socio-economic status, laryngeal papillomatosis, and family history are other etiologic factors (18) . In this study, 91.5% of cases were smokers.
p53 gene is a tumor suppressor gene that weighs 53 kDa and is located on the short arm (17p13.1) of chromosome 17. It controls DNA replication, cell proliferation, and cell death (21) . Various human tumors mutate in the p53 gene. This situation leads to increased stability of this protein and increased immune staining. However, HPV-related cancers generally do not mutate in p53. It is revealed that the E6 protein of HPV bonds to p53 and its degradation. Cells that express HPV E6 protein can not accumulate significant levels of p53 protein pursuant to DNA damage. Therefore, p53 loss of function can be related to mutation, similar to HPV-negative head/neck cancers, or can be related to rapid degradation, as in HPV-related cervical cancers (22) . p53 mutation is reported in 39%-80% of head and neck SCCs (9) . It is reported that excessive p53 expression is related to precancerous and proliferative activity in malignant larynx lesions. In addition, it is reported that some groups are diagnosed with p53 protein at relatively high frequency in precancerous lesions of the larynx (23). These findings suggest there are some disconformities in precancerous lesions of the larynx to indicate the importance of p53. Kazkayası et al. (24) reported no significant relationship between p53 expression and patient age, tumor location, clinical phase, histopathologic grading of tumor, alcohol, and clinical progress; they found a significant relationship between excessive p53 expression and lymph node metastasis. Jacob et al. (25) reported a relationship between HPV infection and increased p53 expression in larynx SCCs. In this study, no relationship was observed between the presence of HPV and p53 staining; however, a significant difference was detected in high-grade tumors (p=0.041). Ki-67 is a nuclear non-histone protein located on chromosome 10. It consists of two molecules, weighing 345 kDa and 395 kDa. G1 and G2 of the cell cycle out of G0 are expressed in the M and S phases (26) . The importance of cell proliferation in larynx SCCs in the prognosis is controversial, because previous studies obtained contradictory results. Açıkalın et al. (13) found a significant correlation between high Ki-67 index and age, T phase, lymph node metastasis, increased recurrence, and short survival period. In the same study, no significant relationship was observed between Ki-67 and tumor localization or histopathologic grade (13). Liu et al. (27) reported that high Ki-67 index correlated with T phase and tumor differentiation and was inversely proportional to disease-free survival. In the same study, no significant relationship was detected between p53 expression and clinicopathologic data, and it was reported that p53 expression had no prognostic value. Lera et al. (28) found no relationship between clinicopathologic features and the expression of Ki-67 and p53 in larynx SCC cases; however, they reported that survival was shorter in cases with high Ki-67 index and that p53 does not influence survival.
In the present study, no significant difference was detected between Ki-67 expression and clinicopathologic parameters, and no correlation was found with p53 expression (p=0.210).
The relationship between HPV and upper-airway pathologies has been known for approximately 1 century (29) . However, in the last 3 decades, viral oncogenic effects have been better revealed in the literature (30) . It has been found that among forms of head and neck cancer, HPV is particularly related to tonsil and oropharyngeal cancers (31) . The cause-and-effect relationship between HPV and SCCs suggests the presence of virus as a risk indicator. The high-risk sub-types of HPV are basically HPV16, 18, 31, 33, 39, 45, 52, 58, 68, and 69. These types play a role in cervical and other anogenital cancers. HPV-6 and HPV-11 are "low-risk" types and are rarely found in malignant lesions (16) .
Immunohistochemistry is performed using a commercially available monoclonal rat antibody. The test can be used for HPV detection during histopathological diagnosis (3). Dönmez et al. (32) detected HPV in 37.5% of cases using the immunohistochemical method and concluded that the staining was technically difficult. In the present study, HPV-16 and HPV-18 antibodies that occurred in the high-risk group and panHPV were detected via the immunohistochemical method. The resulting positive staining rates were 53.2% with pan-HPV and 57.4% with HPV-16. No specific staining was detected with HPV-18. A significant correlation (p=0.000) was detected between panHPV and HPV-16. Immunohistochemistry is a cheaper and easier method of determining the presence of HPV; however, it should be remembered that erroneous staining outcomes may occur due to technical reasons.
In the detection of HPV infections, the prevalent approach involves the display of viral nucleic acids due to non-advantageous virus isolation or serologic tests (15) . Virological tests consist of ISH, Southern blot hybridization, dot-blot hybridization, PCR, and real-time PCR. However, the detection power of ISH is low. In addition, PCR and real-time PCR require specific expensive equipment, such as a thermal cycler, and these methods are not yet common in hospital laboratories (33) . The HybriBio GenoArray test used in this study is a commercial kit that has recently increased in popularity. At the present time, it is used in China, and there are studies supporting its value in high-risk HPV detection (4).
The argument in HPV typing methods results from the lack of a confirmed method for HPV genotyping in formalin-fixed paraffin-embedded tissues. Some methods require special instruments and may not be easily applied in molecular pathology and molecular virology laboratories (34) . Recently, various methods have been developed to present HPV types in wide panels. To date, these methods have only been used in studies in the USA, and it is seen that they have primary benefits for epidemiological studies of HPV infection (8).
Morshed et al. (35) used the PCR method to investigate HPV DNA in paraffin and fresh-frozen tissues in 54 larynx SCCs. They found that paraffin tissues can be used for HPV DNA detection in retrospective studies (35 (16) . In the present study, high-grade Ki-67 staining was observed in cases with panHPV (p=0.004) and HPV-16 (p=0.002) positivity. In addition, Ki-67 staining was significantly high in cases with HPV (PCR) positivity (p=0.01).
The relationship between HPV and larynx cancer has not yet been clarified. Challenges in HPV detection and typing may result from temporary infections, patched involvement, and the various methods used in studies on the presence of HPV and from the differing sensitivities of these methods. Immunohistochemical detection of HPV is a cheap and easy method that can utilize tumor tissues. Although it has some weaknesses, such as subjective assessment and potentially erroneous results due to technical conditions, it remains a good supplementary test for the presence of HPV. For HPV detection, the gold standard method is to study HPV DNA with PCR on fresh tissue; however, paraffin-embedded tissues can also be used to indicate the presence of HPV. The use of the HybriBio HPV GenoArray test has increased in recent years; it is much simpler than other methods and can be a valuable tool to detect HPV-DNA.
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It is hoped that further HPV studies on larger datasets using standard methods will give more definitive results. Identifying the presence of HPV will shed light on the prevention of laryngeal cancers and assist in HPV vaccination activities.
In the literature, it is not clear how the expression of p53 and Ki-67 affects the prognosis in larynx carcinoma. In the present study, it is assumed that the relationship between high grade and high-grade p53 expression can be an indicator of the poor prognosis of p53 expression. In HPV-positive cases, Ki-67 staining was significantly highgrade. The expression of Ki-67 and p53 could be central to a good or poor prognosis in laryngeal SCCs. Further studies are required to better understand the importance of these parameters for the treatment and follow-up of laryngeal SCCs.
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